Your browser doesn't support javascript.
loading
Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels.
Abujrad, H; Mayne, J; Ruzicka, M; Cousins, M; Raymond, A; Cheesman, J; Taljaard, M; Sorisky, A; Burns, K; Ooi, T C.
Afiliação
  • Abujrad H; Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Mayne J; Ottawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Ruzicka M; Division of Nephrology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Chronic Disease Program, Ottawa, Ontario, Canada.
  • Cousins M; Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Raymond A; Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Cheesman J; Division of Nephrology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Taljaard M; Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada.
  • Sorisky A; Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Chronic Disease Program, Ottawa, Ontario, Canada.
  • Burns K; Division of Nephrology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Chronic Disease Program, Ottawa, Ontario, Canada.
  • Ooi TC; Division of Endocrinology and Metabolism, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Chronic Disease Program, Ottawa, Ontario, Canada. Electronic address: tcooi@toh.on.ca.
Atherosclerosis ; 233(1): 123-9, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24529132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Pró-Proteína Convertases / Insuficiência Renal Crônica / LDL-Colesterol Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Atherosclerosis Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Pró-Proteína Convertases / Insuficiência Renal Crônica / LDL-Colesterol Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Atherosclerosis Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá